Generate real-world evidence on biomarker testing patterns, equity, and outcomes using EHR-derived oncology data to drive solutions and action for clients.
Organization
Flatiron Health
National – US
Assess and document payer coverage policies for tumor biomarker and pharmacogenomic testing to inform coverage advocacy.
Organizations
American Cancer Society Cancer Action Network (ACS CAN)
ADVI
National – US
Identify, prioritize, and coordinate issues related to the safe and effective delivery of personalized (precision) health care, and equip pathologists with standardized biomarker reporting tools.
Organization
College of American Pathologists (CAP)
National – US
Track and promote FDA progress in approving personalized medicines and companion diagnostics to inform policy, industry, and stakeholder decisions.
Organization
Personalized Medicine Coalition
National – US
Study barriers, variation, and opportunities to optimize biomarker testing for NSCLC at the point of diagnosis.
National – US
Define and promote the 'Precision Medicine Steward' navigator role for biomarker testing coordination.
Organization
Association of Cancer Care Centers (ACCC)
National – US
Annual summit for experts, professional societies, patient advocate groups, and industry to come together and discuss advancements in precision medicine and identify emerging trends.
National – US
Understand how variation in biopsy, specimen handling, and lab processes can lead to tissue inadequacy for biomarker testing to lead to improved tissue quality and testing practices.
National – US
The mission of the Biomarker Collaborative is to educate patients and all stakeholders on the importance of molecular profiling and the value of introducing patients to their respective biomarker support group upon diagnosis.
Organization
Biomarker Collaborative
National – US
International
Improve testing for RAS/KRAS/NRAS, BRAF, HER2, MSI/MMR biomarkers in frontline mCRC treatment selection.
Organizations
American Society for Clinical Pathology (ASCP)
Pfizer
+1
National – US
Technology-enabled QI grants to improve biomarker testing in clinical practice.
Organizations
American Society of Clinical Oncology (ASCO)
Conquer Cancer
+1
National – US
Generate and disseminate evidence on payer biomarker testing coverage policies and clinical adoption and integration.
Organization
Personalized Medicine Coalition
National – US
Promote guideline-concordant lung cancer staging and comprehensive biomarker testing through a curated set of implementation resources and best-practice guides.
Organization
American Cancer Society National Lung Cancer Roundtable (ACS NLCRT)
National – US
Align insurance coverage of comprehensive biomarker testing coverage in state-regulated plans and Medicaid with latest evidence to reduce financial and access barriers for cancer patients.
Organization
American Cancer Society Cancer Action Network (ACS CAN)
National – US
Multi-stakeholder strategic plan to reduce barriers and achieve universal comprehensive biomarker testing for all eligible NSCLC patients.
Organization
American Cancer Society National Lung Cancer Roundtable (ACS NLCRT)
National – US
Analyze differences across published biomarker testing guidelines (timing, methodology, scope of targets) that create inconsistencies in clinical practice.
Organization
American Cancer Society National Lung Cancer Roundtable (ACS NLCRT)
National – US
Raise awareness of and improve access to biomarker testing for gastrointestinal cancer patients globally through education and advocacy.
Organization
GI Cancers Alliance
National – US
International